TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
ImmuPharma ( (GB:IMM) ) has issued an update.
ImmuPharma PLC announced the exercise of 500,000 warrants over new ordinary shares, resulting in a consideration of £25,000. The new shares, representing 0.10% of the company’s enlarged issued share capital, will be admitted to trading on the AIM market of the London Stock Exchange, enhancing the company’s market presence and potentially impacting shareholder interests.
More about ImmuPharma
ImmuPharma PLC is a specialty biopharmaceutical company focused on discovering and developing peptide-based therapeutics. The company’s portfolio includes innovative peptide therapeutics targeting autoimmune diseases and anti-infectives.
Average Trading Volume: 8,743,397
Technical Sentiment Signal: Buy
Current Market Cap: £87.95M
Find detailed analytics on IMM stock on TipRanks’ Stock Analysis page.